Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H Kramer

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Brain Injury|May 1, 1993
AIDS knowledge and risk behaviours among traumatic brain injury survivors with coexisting substance abuseT H Kramer, D F Nelson, P W Li
Pharmacotherapy|January 1, 1989
Transdermal fentanyl: pharmacokinetics and preliminary clinical evaluationP M Plezia, T H Kramer, J Linford, et al.
Anesthesia and Analgesia|November 1, 1990
Contributions of liver perfusion flow rate and enzyme inhibition to altered verapamil clearance with halothane: a study in the isolated perfused rat liverE J Frink, T H Kramer, S M Banchy, et al.
Pharmacotherapy|January 1, 1990
The influence of enteral feedings on sustained-release theophylline absorptionP M Plezia, S M Thornley, T H Kramer, et al.
Proceedings of the Western Pharmacology Society|January 1, 1989
RX809055AX in vivo: a long lasting opioid antagonist at mu and delta receptorsP K Lemcke, E A Ayres, T H Kramer, et al.
Proceedings of the Western Pharmacology Society|January 1, 1991
In vitro evaluation of a casomorphin related pentapeptide, a competitive mu opioid receptor antagonistP Davis, D Tourwe, N Delaet, et al.
Life Sciences|January 1, 1997
Extraordinary potency of a novel delta opioid receptor agonist is due in part to increased efficacyT H Kramer, H Bartosz-Bechowski, P Davis, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligandsT H Kramer, P Davis, V J Hruby, et al.
NIDA Research Monograph|January 1, 1989
Novel [D-Pen2, D-Pen5]enkephalin derivatives with increased sigma receptor potency and selectivity: potential tools for opioid pharmacologyT F Burks, T H Kramer, P Davis, et al.
Anesthesia and Analgesia|January 1, 1995
The effect of esmolol given during cardiopulmonary bypassR C Cork, T H Kramer, B Dreischmeier, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Brain Injury|May 1, 1993
AIDS knowledge and risk behaviours among traumatic brain injury survivors with coexisting substance abuseT H Kramer, D F Nelson, P W Li
Pharmacotherapy|January 1, 1989
Transdermal fentanyl: pharmacokinetics and preliminary clinical evaluationP M Plezia, T H Kramer, J Linford, et al.
Anesthesia and Analgesia|November 1, 1990
Contributions of liver perfusion flow rate and enzyme inhibition to altered verapamil clearance with halothane: a study in the isolated perfused rat liverE J Frink, T H Kramer, S M Banchy, et al.
Pharmacotherapy|January 1, 1990
The influence of enteral feedings on sustained-release theophylline absorptionP M Plezia, S M Thornley, T H Kramer, et al.
Proceedings of the Western Pharmacology Society|January 1, 1989
RX809055AX in vivo: a long lasting opioid antagonist at mu and delta receptorsP K Lemcke, E A Ayres, T H Kramer, et al.
Proceedings of the Western Pharmacology Society|January 1, 1991
In vitro evaluation of a casomorphin related pentapeptide, a competitive mu opioid receptor antagonistP Davis, D Tourwe, N Delaet, et al.
Life Sciences|January 1, 1997
Extraordinary potency of a novel delta opioid receptor agonist is due in part to increased efficacyT H Kramer, H Bartosz-Bechowski, P Davis, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligandsT H Kramer, P Davis, V J Hruby, et al.
NIDA Research Monograph|January 1, 1989
Novel [D-Pen2, D-Pen5]enkephalin derivatives with increased sigma receptor potency and selectivity: potential tools for opioid pharmacologyT F Burks, T H Kramer, P Davis, et al.
Anesthesia and Analgesia|January 1, 1995
The effect of esmolol given during cardiopulmonary bypassR C Cork, T H Kramer, B Dreischmeier, et al.
Pageof 6